logo
Share SHARE
FONT-SIZE Plus   Neg

AstraZeneca Begins Olaparib Phase III Trial; Reverses $285 Mln Charge

AstraZeneca PLC (AZN.L,AZN) Wednesday said it enrolled the first patient in the Phase III SOLO, or Study of OLaparib in Ovarian cancer, programme. Olaparib, an innovative oral poly ADP ribose polymerase inhibitor is being investigated for the treatment of BRCA mutated ovarian cancer in SOLO. The clinical development is designed to study the benefit, progression free survival, of olaparib as a maintenance monotherapy in BRCA mutated ovarian cancer patients who are in complete or partial response following platinum-based chemotherapy in the first line setting, SOLO 1, and relapsed setting, SOLO 2.

A pre-tax impairment charge of $285 million, which was incurred in December 2011 after deciding not to progress olaparib into phase III, will be reversed in the third quarter of 2013, following the start of the programme. This reversal will be excluded from the core earning per share, the company said.

The SOLO 1 study is being conducted in collaboration with the Gynecologic Oncology Group and the SOLO 2 study with the European Network of Gynaecological Oncological Trial Groups. Both trials are randomised, double blind, placebo controlled studies that utilise the tablet formulation of olaparib at a dose of 300mg twice daily.

Separately, Myriad Genetics, Inc. (MYGN) said it is expanding its collaboration agreement with AstraZeneca to provide companion diagnostics for the olaparib Phase 3 clinical development program. Pursuant to the agreement, Myriad will build out a new laboratory within its Salt Lake City facility in accordance with U.S. Food and Drug Administration regulations for companion diagnostic devices.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
New York's landmark Waldorf Astoria hotel will be shut for up to three years starting spring 2017 as its Chinese owner Anbang Insurance Group Co. plans to convert most of its 1,413 hotel rooms into luxury condominiums, according to media reports. Starbucks Corp., for the first time, will offer a single-origin coffee from India to customers in the U.S. under an expansion of the specialty coffee retailer's joint venture partnership with Indian conglomerate Tata Group. Starbucks customers in the U.S. will be able to experience a rare, small-lot coffee from the Tata Nullore Estates located in the Coorg region of India. For the Independence Day week-end, starting June 30, travel volume will be a record this year, predicts the American Automobile Association or AAA. Friday and Monday afternoons are expected to be the peak hours. Cruising seems to be a favorite travel mode this year with 35 percent increase from last...
comments powered by Disqus
Follow RTT